{"id":"W1987514490","doi":"10.1161/circresaha.112.276741","title":"Oral Direct Factor Xa Inhibitors","year":2012,"lang":"en","type":"review","venue":"Circulation Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Rivaroxaban; Apixaban; Edoxaban; Warfarin; Medicine; Intensive care medicine; Dabigatran; Discovery and development of direct thrombin inhibitors; Pharmacodynamics; Anticoagulant; Pharmacology; Vitamin K antagonist; Thrombin; Atrial fibrillation; Internal medicine; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001306005,0.0002680839,0.001184741,0.0009489248,0.0001812198,0.00009036101,0.0001337785,0.0003701384,0.001553537],"category_scores_gemma":[0.0004652608,0.0002070088,0.0006069611,0.001153549,0.00008698287,0.0001658867,0.0001410225,0.0005846741,0.002234336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003564437,"about_ca_system_score_gemma":0.0002645433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002882006,"about_ca_topic_score_gemma":0.000002418801,"domain_scores_codex":[0.9968487,0.0005052956,0.0005891941,0.0003895573,0.001142857,0.0005243857],"domain_scores_gemma":[0.9983146,0.0005080239,0.0001624597,0.0005072101,0.0002550262,0.0002527061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008257605,0.000009362946,0.007363286,0.007305435,0.0001761608,0.000003874061,0.00003658486,0.000001235908,0.000001433984,0.0002280901,0.001843626,0.9830226],"study_design_scores_gemma":[0.0002334638,0.00002254433,0.004822585,0.001580242,0.000393066,0.000004259542,0.000009492785,0.00001451443,0.000001016274,0.00001668184,0.9927158,0.0001862732],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008572547,0.9821133,0.00001648877,0.000178207,0.0006177139,0.002044022,0.00001258001,0.0001141251,0.01481783],"genre_scores_gemma":[0.004914393,0.9815314,0.00004535865,0.00001132871,0.003321588,0.00002612626,0.0004026406,0.00007937146,0.00966784],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9908723,"threshold_uncertainty_score":0.9993592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.626058490618074,"score_gpt":0.5528008094413012,"score_spread":0.07325768117677278,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}